EP0069513A2 — Indole thromboxane synthetase inhibitors, processes for their preparation, and pharmaceutical compositions containing them
Assigned to Pfizer Ltd Great Britain · Expires 1983-01-12 · 43y expired
What this patent protects
Selective thromboxane synthetase inhibitors of the formula:- <CHEM> where R<1> is H or C1-C4 alkyl; R<2> is H, C1-C4 alkyl, C1-C4 alkoxy or halo; R<3> is H or methyl; Y is -COOH, -COO(C1-C4 alkyl) or -CONH2; and Z is 1-imidazolyl or 3-pyridyl; and…
USPTO Abstract
Selective thromboxane synthetase inhibitors of the formula:- <CHEM> where R<1> is H or C1-C4 alkyl; R<2> is H, C1-C4 alkyl, C1-C4 alkoxy or halo; R<3> is H or methyl; Y is -COOH, -COO(C1-C4 alkyl) or -CONH2; and Z is 1-imidazolyl or 3-pyridyl; and their pharmaceutical acceptable salts; processes for preparing them, and pharmaceutical compositions containing them.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.